NO780197L - Fremgangsmaate for fremstilling av lysin-saltet av alfa-metyl-(2-isopropyl-5-indanyl)eddiksyre - Google Patents
Fremgangsmaate for fremstilling av lysin-saltet av alfa-metyl-(2-isopropyl-5-indanyl)eddiksyreInfo
- Publication number
- NO780197L NO780197L NO780197A NO780197A NO780197L NO 780197 L NO780197 L NO 780197L NO 780197 A NO780197 A NO 780197A NO 780197 A NO780197 A NO 780197A NO 780197 L NO780197 L NO 780197L
- Authority
- NO
- Norway
- Prior art keywords
- isopropyl
- acetic acid
- indanyl
- methyl
- salt
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title claims description 4
- 238000000034 method Methods 0.000 title claims 5
- MRASYQFTHLLRCS-UHFFFAOYSA-N 2-(2-propan-2-yl-2,3-dihydro-1h-inden-5-yl)acetic acid Chemical compound C1=C(CC(O)=O)C=C2CC(C(C)C)CC2=C1 MRASYQFTHLLRCS-UHFFFAOYSA-N 0.000 title 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical class NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 title 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims description 14
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 14
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims description 12
- RYDUZJFCKYTEHX-UHFFFAOYSA-N 2-(2-propan-2-yl-2,3-dihydro-1h-inden-5-yl)propanoic acid Chemical compound C1=C(C(C)C(O)=O)C=C2CC(C(C)C)CC2=C1 RYDUZJFCKYTEHX-UHFFFAOYSA-N 0.000 claims description 8
- 239000004472 Lysine Substances 0.000 claims description 8
- 239000002904 solvent Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 claims description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 claims description 3
- 230000001476 alcoholic effect Effects 0.000 claims description 2
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 claims description 2
- 229960002327 chloral hydrate Drugs 0.000 claims description 2
- 239000003960 organic solvent Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000000243 solution Substances 0.000 description 13
- 239000000047 product Substances 0.000 description 5
- 241001465754 Metazoa Species 0.000 description 3
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 230000000202 analgesic effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 239000012153 distilled water Substances 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 230000008018 melting Effects 0.000 description 2
- 238000002844 melting Methods 0.000 description 2
- 125000000896 monocarboxylic acid group Chemical group 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000700159 Rattus Species 0.000 description 1
- 239000000730 antalgic agent Substances 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 230000003356 anti-rheumatic effect Effects 0.000 description 1
- 239000003435 antirheumatic agent Substances 0.000 description 1
- 239000007982 barbital buffer Substances 0.000 description 1
- 229960000796 barbital sodium Drugs 0.000 description 1
- FTOAOBMCPZCFFF-UHFFFAOYSA-N barbitone sodium Natural products CCC1(CC)C(=O)NC(=O)NC1=O FTOAOBMCPZCFFF-UHFFFAOYSA-N 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000003480 fibrinolytic effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 210000000548 hind-foot Anatomy 0.000 description 1
- 125000003392 indanyl group Chemical group C1(CCC2=CC=CC=C12)* 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 210000000664 rectum Anatomy 0.000 description 1
- RGHFKWPGWBFQLN-UHFFFAOYSA-M sodium;5,5-diethylpyrimidin-3-ide-2,4,6-trione Chemical compound [Na+].CCC1(CC)C([O-])=NC(=O)NC1=O RGHFKWPGWBFQLN-UHFFFAOYSA-M 0.000 description 1
- 230000003637 steroidlike Effects 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/42—Unsaturated compounds containing hydroxy or O-metal groups
- C07C59/48—Unsaturated compounds containing hydroxy or O-metal groups containing six-membered aromatic rings
- C07C59/50—Mandelic acid
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB422677 | 1977-02-02 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO780197L true NO780197L (no) | 1978-08-03 |
Family
ID=9773125
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO780197A NO780197L (no) | 1977-02-02 | 1978-01-19 | Fremgangsmaate for fremstilling av lysin-saltet av alfa-metyl-(2-isopropyl-5-indanyl)eddiksyre |
Country Status (16)
| Country | Link |
|---|---|
| JP (1) | JPS5396313A (el) |
| AT (1) | ATA52878A (el) |
| AU (1) | AU3272178A (el) |
| BE (1) | BE862834A (el) |
| DD (1) | DD133940A5 (el) |
| DE (1) | DE2803205A1 (el) |
| DK (1) | DK47278A (el) |
| ES (1) | ES466481A1 (el) |
| FR (1) | FR2379511A1 (el) |
| GR (1) | GR62849B (el) |
| NL (1) | NL7801204A (el) |
| NO (1) | NO780197L (el) |
| PT (1) | PT67572B (el) |
| SE (1) | SE7801087L (el) |
| SU (1) | SU667130A3 (el) |
| ZA (1) | ZA78403B (el) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3328401A1 (de) * | 1983-08-05 | 1985-02-21 | Merckle GmbH, 7902 Blaubeuren | Injizierbare loesung zur behandlung von entzuendungen |
| IT1197289B (it) * | 1986-09-26 | 1988-11-30 | S I F I Societa Ind Farmaceuti | Sale di lisina dell'acido 4-bifenilacetico e sue composizioni oftalmiche |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH592598A5 (el) * | 1973-10-30 | 1977-10-31 | Hexachimie | |
| IT1059677B (it) * | 1974-03-22 | 1982-06-21 | Neopharmed Spa | Sale di lisina ad azione terapeutica |
-
1978
- 1978-01-09 FR FR7800450A patent/FR2379511A1/fr not_active Withdrawn
- 1978-01-12 BE BE2056598A patent/BE862834A/xx unknown
- 1978-01-19 NO NO780197A patent/NO780197L/no unknown
- 1978-01-23 ZA ZA00780403A patent/ZA78403B/xx unknown
- 1978-01-23 GR GR55241A patent/GR62849B/el unknown
- 1978-01-24 PT PT67572A patent/PT67572B/pt unknown
- 1978-01-25 AT AT52878A patent/ATA52878A/de not_active IP Right Cessation
- 1978-01-25 DE DE19782803205 patent/DE2803205A1/de active Pending
- 1978-01-25 AU AU32721/78A patent/AU3272178A/en active Pending
- 1978-01-27 JP JP818678A patent/JPS5396313A/ja active Pending
- 1978-01-30 ES ES466481A patent/ES466481A1/es not_active Expired
- 1978-01-30 SE SE7801087A patent/SE7801087L/xx unknown
- 1978-01-31 DD DD78203487A patent/DD133940A5/xx unknown
- 1978-02-01 DK DK47278A patent/DK47278A/da unknown
- 1978-02-01 SU SU782571854A patent/SU667130A3/ru active
- 1978-02-02 NL NL7801204A patent/NL7801204A/xx not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| DE2803205A1 (de) | 1978-08-03 |
| DK47278A (da) | 1978-08-03 |
| SU667130A3 (ru) | 1979-06-05 |
| PT67572B (fr) | 1979-06-20 |
| SE7801087L (sv) | 1978-08-03 |
| GR62849B (en) | 1979-06-20 |
| JPS5396313A (en) | 1978-08-23 |
| ES466481A1 (es) | 1979-06-01 |
| ZA78403B (en) | 1979-01-31 |
| AU3272178A (en) | 1979-08-02 |
| FR2379511A1 (fr) | 1978-09-01 |
| BE862834A (fr) | 1978-07-12 |
| DD133940A5 (de) | 1979-01-31 |
| ATA52878A (de) | 1979-02-15 |
| NL7801204A (nl) | 1978-08-04 |
| PT67572A (fr) | 1978-02-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE3885889T2 (de) | (r)5-pentylamino-5-oxopentanesäure-derivate mit anticholecystokininwirkung. | |
| DE3883495T2 (de) | Enantiomere Derivate von Aminosäure, Verfahren zu deren Herstellung und deren therapeutische Verwendung. | |
| JP3231042B2 (ja) | ２−（２，６−ジ−ハロ−フェニルアミノ）フェニル酢酸の誘導体の硝酸エステルおよびその製造法 | |
| DE69311130T2 (de) | Arylpropionsäurederivat, verfahren zu seiner herstellung und seine verwendung als analgetikum | |
| DE2065635C3 (de) | 10-Dioxo-11 -methyldibenzothiazepinderivate, Verfahren zu ihrer Herstellung und sie enthaltende pharmazeutische Zubereitungen | |
| DE2634288B2 (el) | ||
| FR2513250A1 (fr) | Nouvelles cyclobutene-3,4-diones substituees | |
| NO144211B (no) | Analogifremgangsmaate til fremstilling av nye tyrosinderivater med farmasoeytisk virkning paa glatte muskler | |
| JP3119738B2 (ja) | Ｎ−フェニル−２−シアノ−３−ヒドロキシクロトンアミド誘導体および免疫調整性を有する医薬品としてのその使用 | |
| KR0156231B1 (ko) | 인도메타신의 2가 전이 금속염을 함유하는 조성물 | |
| JP7050336B2 (ja) | 重水素化化合物及びその医薬的用途 | |
| DE2446100C3 (de) | Phenoxyalkancarbonsäureamide von Thiazolidincarbonsäuren, Verfahren zu ihrer Herstellung und Arzneimittel | |
| DE1960910B2 (de) | Benzylidenamino-oxyalkancarbonsäuren und deren Derivate, Verfahren zu deren Herstellung und diese enthaltende pharmazeutische Präparate | |
| PT100216B (pt) | N-{{4,5-di-hidroxi- e 4,5,8-tri-hidroxi-9,10-di-hidro-9,10-dioxo-2-antracentil} carbonil}-aminoacidos uteis na terapia de afeccoes osteoarticulares, processo para a sua preparacao e composicoes farmaceuticas que os contem | |
| DE1902694C3 (de) | 2- (3-Trifluormethylanilino) -nicotin-säureamidderivate, Verfahren zu ihrer Herstellung und sie enthaltende Arzneimittel | |
| SU791241A3 (ru) | Способ получени производных 4,5,6,7-тетрагидроимидазо 4,5-с пиридина | |
| DE69108580T2 (de) | Optisch aktives Derivat der d-2-(6-Methoxy-2-naphthyl)-propionsäure und es enthaltende pharmazeutische Zusammensetzungen. | |
| JPS5910563A (ja) | α−（Ｎ−ピロリル）−フエニル酢酸誘導体およびその製造方法 | |
| DE1953342C3 (de) | 1 -(3-Cyan-3,3-diphenylpropy1)-4phenylisonipecotinsäure | |
| SU1537136A3 (ru) | Способ получени 3-амино-4- @ 2-[(2-гуанидинотиазол-4-ил)метилтио]этиламино @ -1,2,5-тиадиазола или его фармацевтически приемлемой кислотно-аддитивной соли | |
| DE3007213A1 (de) | O- und m-methylthiophenylaethylamin, verfahren zu ihrer herstellung und pharmazeutische zubereitungen | |
| DE2403752A1 (de) | Cis-(2,4-dimethoxyphenyl)-3-crotonsaeure, salze dieser saeure, und diese verbindungen enthaltende pharmazeutische mittel | |
| CA1265160A (en) | Gem-dihalo and tetrahalo-1,12-diamino-4,9-diaza- dodecanes | |
| DE2418467C3 (de) | Substituierte Benzanilide und Verfahren zu deren Herstellung | |
| DE1793625C3 (de) | Verfahren zur Herstellung von beta-Aminoäthylestem von 1-Alkoxy-1phenyl-1 eckige Klammer auf thienyl-(2) eckige Klammer zu -essigsauren. Ausscheidung aus: 1543834 |